BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bennet SM, Keshteli AH, Bercik P, Madsen KL, Reed D, Vanner SJ. Application of metabolomics to the study of irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13884. [PMID: 32426922 DOI: 10.1111/nmo.13884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mishima Y, Ishihara S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci. 2020;21. [PMID: 33212919 DOI: 10.3390/ijms21228664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
2 Shah ED, Brenner DM, Chen VL. Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System. Dig Dis Sci 2021. [PMID: 33779879 DOI: 10.1007/s10620-021-06963-x] [Reference Citation Analysis]
3 Inczefi O, Bacsur P, Resál T, Keresztes C, Molnár T. The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease. Front Nutr 2022;9:718710. [PMID: 35548572 DOI: 10.3389/fnut.2022.718710] [Reference Citation Analysis]
4 Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest 2022;52:e13702. [PMID: 34738648 DOI: 10.1111/eci.13702] [Reference Citation Analysis]
5 Mars RAT, Frith M, Kashyap PC. Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic? Gastroenterology 2021;160:538-55. [PMID: 33253687 DOI: 10.1053/j.gastro.2020.10.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]